A new boron agent drastically improves the effectiveness of boron neutron capture therapy for glioblastoma, demonstrate researchers at Tokyo Tech. The agent is selectively absorbed by brain tumor ...
Distinguishing head and neck cancer metastasis from second primary squamous lung cancer in the genomic era. Cisplatin/UFUR/irinotecan triple combination therapy for ...
Boron neutron capture therapy (BNCT) is a binary radiotherapeutic modality that exploits the nuclear capture reaction between the stable isotope boron-10 and low-energy neutrons. Following selective ...
Companies sign MOU to develop proton therapy and boron neutron capture therapy integration | Jun. 26, 2026 13:09 ...
Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: Implications for hippocampal sparing irradiation. This is an ASCO Meeting Abstract from the ...
IRVINE, Calif.--(BUSINESS WIRE)--TAE Life Sciences, in collaboration with Kyoto University and Principal Investigator Dr. Fuyuhiko Tamanoi, is pleased to announce groundbreaking preclinical results in ...
ANSTO researchers have made significant progress on a new approach to cancer treatment Neutron Capture Enhanced Particle Therapy (NCEPT), which has the potential to improve outcomes for patients with ...
Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron ...
— Leo Cancer Care’s upright patient positioning system to be integrated into Neutron Therapeutics’ nuBeam® therapy platform — NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Aviko Radiopharmaceuticals, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results